SB580: Bill Text

LRB-4787/1

MED:cdc

2019 - 2020 LEGISLATURE

2019 Senate BILL 580

November 22, 2019 - Introduced by Senators Kooyenga, Cowles and Wanggaard, cosponsored by Representatives Nygren, Novak, Snyder, Petersen, Kitchens, Quinn, Felzkowski, Edming, Kulp, Magnafici, Plumer, Horlacher, Rohrkaste, Knodl, Tusler, Petryk, Dittrich, Tranel, Thiesfeldt, Jagler, Spiros, Mursau, Ramthun, Born, Billings and Bowen. Referred to Committee on Health and Human Services.

SB580,1,3 An Act to amend 227.01 (13) (zk); and to create 448.039 of the statutes; relating to: guidelines regarding the treatment of neonatal abstinence syndrome.

Analysis by the Legislative Reference Bureau

This bill requires the Medical Examining Board to issue guidelines regarding best practices for the treatment of neonatal abstinence syndrome, a condition that may occur in a newborn following the discontinuation of fetal exposure to substances that were used by the mother during pregnancy.

For further information see the state fiscal estimate, which will be printed as an appendix to this bill.

The people of the state of Wisconsin, represented in senate and assembly, do enact as follows:

SB580,1 Section 1. 227.01 (13) (zk) of the statutes is amended to read:

SB580,1,5 227.01 (13) (zk) Are guidelines issued under s. 440.035 (2m) (b) or 448.039.

SB580,2 Section 2. 448.039 of the statutes is created to read:

SB580,2,4 448.039 Neonatal abstinence syndrome guidelines. The board shall issue guidelines regarding best practices for the treatment of neonatal abstinence syndrome. In developing the guidelines under this section, the board shall consult with obstetricians and gynecologists, pediatricians, and relevant state associations to ensure that the guidelines are appropriate and reflective of evidence-based best practices for the treatment of neonatal abstinence syndrome.

SB580,2,5 (End)